ifosfamide has been researched along with Leukemia, Prolymphocytic in 2 studies
Leukemia, Prolymphocytic: A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billio, A | 1 |
| Pescosta, N | 1 |
| Rosanelli, C | 1 |
| Fabris, P | 1 |
| Coser, P | 1 |
| Styczynski, J | 1 |
| Pieters, R | 1 |
| Huismans, DR | 1 |
| Schuurhuis, GJ | 1 |
| Wysocki, M | 1 |
| Veerman, AJ | 1 |
2 other studies available for ifosfamide and Leukemia, Prolymphocytic
| Article | Year |
|---|---|
A brief intensive chemotherapy in T-prolymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarab | 2000 |
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child | 2000 |